A cautionary tale: Fatal lactic acidosis complicating nucleoside analogue and metformin therapy [2] (multiple letters)

Clinical Infectious Diseases

Volumn 37, Issue 2, 2003, Pages 315-316

  Worth, Leon ^a   Elliott, Julian ^a   Anderson, Jonathan ^b   Sasadeusz, Joe ^a   Street, Alan ^a   Lewin, Sharon ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b Carlton Clinic   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; GANCICLOVIR; METFORMIN; NUCLEOSIDE ANALOG; STAVUDINE; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIDIABETIC AGENT; NUCLEOSIDE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; CARDIOVASCULAR RISK; CASE REPORT; DOSE RESPONSE; FATTY LIVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; LETTER; LIPODYSTROPHY; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT PLANNING; VIRUS LOAD; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; FATALITY; MIDDLE AGED;

ACIDOSIS, LACTIC; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; FATAL OUTCOME; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; NUCLEOSIDES; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0042267283     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375850     Document Type: Letter

References (12)

1. John M, Moore CB, James IR, et al. Chronic hyperlactataemia in HIV-infected patients taking antiretroviral therapy. AIDS 2001; 15:717-23.
2. Hadigan C, Rabe J, Grinspoon S. Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients with fat redistribution and insulin resistance. J Clin Endocrinol Metab 2002; 87:4611-5.
3. Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Risk of lactic acidosis with metformin therapy. Arch Intern Med 2002; 162:434-7.
4. Brinkman K. Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors. Clin Infect Dis 2000; 31:167-9.
5. Gan SC, Barr J, Arieff AI, Pearl RG. Biguanide-associated lactic acidosis: case report and review of the literature. Arch Intern Med 1992; 152:2333-6.
6. Claessens Y-E, Cariou A, Chiche J-D, Dauriat G, Dhainaut J-F. L-carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues. AIDS 2000; 14:472-3.
7. Fouty B, Frerman F, Reves R. Riboflavin to treat nucleoside analogue-induced lactic acidosis. Lancet 1998; 352:291-2.
8. Falcó V, Rodríguez D, Ribera E, et al. Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis 2002; 34:838-46.
9. Brinkman K, Vrouenraets S, Kauffmann R, Weigel H, Frissen J. Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis. AIDS 2000; 14:2801-2.
10. Bailey CJ, Turner RC. Drug therapy: metforrain. N Engl J Med 1996; 334:574-9.
11. Chodock R, Mylonakis E, Shemin D, et al. Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis-role of haemodialysis treatment. Nephrol Dial Transplant 1999; 14:2484-6.
12. Roy P-M, Gouello J-P, Pennison-Besnier I, Chennebault J-M. Severe lactic acidosis induced by nucleoside analogues in an HIV-infected man. Ann Emerg Med 1999; 34:282-4.